Valiant Organics Limited (BOM:540145)
India · Delayed Price · Currency is INR 344.15
-13.65 (-3.81%)
At close: Nov 9, 2026
Valiant Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 9,128 | 7,388 | 7,188 | 7,231 | 10,518 | 11,533 |
Other Revenue | 31.11 | - | - | - | - | - |
| 9,159 | 7,388 | 7,188 | 7,231 | 10,518 | 11,533 | |
Revenue Growth | 21.74% | 2.78% | -0.59% | -31.25% | -8.80% | 52.79% |
Cost of Revenue | 5,716 | 4,540 | 4,746 | 5,079 | 7,098 | 7,944 |
Gross Profit | 3,443 | 2,847 | 2,442 | 2,152 | 3,420 | 3,588 |
Selling, General & Admin | 520.34 | 488.57 | 449.89 | 503.22 | 473 | 376.4 |
Other Operating Expenses | 1,665 | 1,477 | 1,452 | 1,270 | 1,299 | 1,154 |
Operating Expenses | 2,594 | 2,361 | 2,260 | 2,123 | 2,064 | 1,827 |
Operating Income | 849.66 | 486.12 | 181.91 | 29.09 | 1,356 | 1,762 |
Interest Expense | -182.08 | -181.99 | -240.54 | -163.43 | -107.93 | -64.79 |
Interest & Investment Income | 36.68 | 36.68 | 21.74 | 3.14 | 4.03 | 8.63 |
Earnings From Equity Investments | 55.64 | -11.2 | -7.62 | -15.65 | - | - |
Currency Exchange Gain (Loss) | 8.84 | 8.84 | 1.41 | 4.16 | -5.36 | -9.23 |
Other Non Operating Income (Expenses) | 23.68 | 23.68 | 49.44 | 56.34 | 51.52 | 65.2 |
EBT Excluding Unusual Items | 792.43 | 362.14 | 6.34 | -86.35 | 1,298 | 1,761 |
Gain (Loss) on Sale of Investments | - | - | 13.57 | 30.09 | 24.13 | - |
Gain (Loss) on Sale of Assets | - | - | 1.61 | 3.44 | 0.64 | 0.35 |
Other Unusual Items | 57.21 | 57.21 | - | -34.11 | 48.98 | - |
Pretax Income | 849.63 | 419.35 | 21.52 | -86.93 | 1,372 | 1,762 |
Income Tax Expense | 190.41 | 87.06 | 55.79 | -2.97 | 346.16 | 482.57 |
Earnings From Continuing Operations | 659.23 | 332.29 | -34.28 | -83.97 | 1,026 | 1,279 |
Minority Interest in Earnings | -2.09 | 0.07 | -3.09 | 0.05 | -144.43 | -146.29 |
Net Income | 657.14 | 332.36 | -37.36 | -83.91 | 881.21 | 1,133 |
Net Income to Common | 657.14 | 332.36 | -37.36 | -83.91 | 881.21 | 1,133 |
Net Income Growth | 179.24% | - | - | - | -22.21% | -1.12% |
Shares Outstanding (Basic) | 28 | 28 | 28 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 27 | 28 | 28 |
Shares Change | 1.75% | 1.55% | 1.11% | -2.43% | 0.03% | - |
EPS (Basic) | 23.52 | 11.87 | -1.35 | -3.07 | 32.45 | 41.72 |
EPS (Diluted) | 23.51 | 11.86 | -1.35 | -3.07 | 31.50 | 40.51 |
EPS Growth | 174.45% | - | - | - | -22.24% | -1.12% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -237.42 | 584.58 | 256.03 | 90.67 | 862.19 | -1,534 |
Free Cash Flow Per Share | -8.49 | 20.86 | 9.28 | 3.32 | 30.82 | -54.86 |
Dividend Per Share | - | - | - | - | 1.000 | 3.500 |
Dividend Growth | - | - | - | - | -71.43% | -30.00% |
Gross Margin | 37.60% | 38.54% | 33.97% | 29.76% | 32.51% | 31.12% |
Operating Margin | 9.28% | 6.58% | 2.53% | 0.40% | 12.89% | 15.27% |
Profit Margin | 7.17% | 4.50% | -0.52% | -1.16% | 8.38% | 9.82% |
Free Cash Flow Margin | -2.59% | 7.91% | 3.56% | 1.25% | 8.20% | -13.30% |
EBITDA | 1,255 | 878.02 | 535.28 | 375.28 | 1,643 | 2,037 |
EBITDA Margin | 13.70% | 11.88% | 7.45% | 5.19% | 15.62% | 17.67% |
D&A For EBITDA | 405.22 | 391.89 | 353.37 | 346.19 | 287.34 | 275.92 |
EBIT | 849.66 | 486.12 | 181.91 | 29.09 | 1,356 | 1,762 |
EBIT Margin | 9.28% | 6.58% | 2.53% | 0.40% | 12.89% | 15.27% |
Effective Tax Rate | 22.41% | 20.76% | 259.30% | - | 25.23% | 27.39% |
Revenue as Reported | 9,228 | 7,457 | 7,275 | 7,324 | 10,598 | 11,607 |